IBB vs VIG
iShares Biotechnology ETF vs Vanguard Dividend Appreciation ETF
- • VIG has the lower expense ratio at 0.04% vs 0.44% for IBB.
- • VIG pays a higher dividend yield (1.51%).
Side-by-side metrics
| Metric | IBB | VIG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.04% |
Dividend yield Trailing 12-month yield. | 0.22% | 1.51% |
AUM Assets under management — bigger funds are typically more liquid. | $9.09B | $129.46B |
YTD return | 16.44% | 8.91% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 0.75 |
P/E ratio | 24.79 | 26.66 |
Last price | $196.62 | $238.89 |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
VIG top holdings
| AVGO | Broadcom Inc | 5.39% |
| AAPL | Apple Inc | 4.55% |
| MSFT | Microsoft Corp | 4.26% |
| LLY | Eli Lilly and Co | 3.83% |
| JPM | JPMorgan Chase & Co | 3.31% |
| XOM | Exxon Mobil Corp | 2.66% |
| JNJ | Johnson & Johnson | 2.38% |
| V | Visa Inc Class A | 2.24% |
| WMT | Walmart Inc | 2.22% |
| CSCO | Cisco Systems Inc | 2.08% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VIG
VIG (Vanguard Dividend Appreciation ETF) is US companies with a record of growing dividends. Managed by Vanguard, the fund carries $129.5B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.51%. Its largest holding is Broadcom Inc (AVGO), which represents 5.4% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 4.4%.